Abstract
Gliomas are hard to treat. Their prognosis has improved little over the past few decades. Fundamental therapeutic challenges such as treatment resistance, malignant progression and tumour recurrence persist. New strategies are needed to advance the management and treatment of gliomas. Here, we focus on where those new strategies could emerge. We consider how recent advances in our understanding of the biology of adult gliomas is informing new approaches to their treatment.
Original language | English |
---|---|
Article number | 1563 |
Number of pages | 9 |
Journal | Journal of Neurology |
Early online date | 15 Jun 2020 |
DOIs | |
Publication status | E-pub ahead of print - 15 Jun 2020 |